Search

Skip to main content Lab Members Hua-Kang Wu, Ph.D. Research Scientist Hua-Kang earned his Ph.D. in Immuno-hematology from the University of Tokyo, Japan. He completed his postdoctoral training in Molecular Cancer Genetics at the University of Toronto, Canada, and gained further scientific experience…

Skip to main content Publications 2025 Immunotherapeutic targeting of NY-ESO-1 in malignant meningiomas with TCR-transduced T-cells. Sun MZ , Contreras E, Treger J, Imbroane M, Orpilla J, Ko M, Reynoso J, Khattab S, Lai TJ, Tsang JE, Vitte J, Giovannini M, Liau LM, Prins R, Everson RG.J Neurooncol. 2…

Our research is aimed at innovating and translating computational technology to advance biomedical research and medical diagnoses/treatments.

Skip to main content News See our latest Lab news . June 2025 The Azab Lab is presenting for the Southwestern Medical Foundation Trustees Today we had a fantastic opportunity to showcase our Lab's research to the Southwestern Medical Foundation Trustees, focusing on advancing localized therapies for …

Skip to main content Contact Us Dr. Azab office UT Southwestern Medical Center 2336 Inwood Rd. EA Building, Floor 3, Room 410B Dallas, Texas 75235-7323 Phone +1(214) 645-9014 Email Dr. Azab Laboratory UT Southwestern Medical Center 2336 Inwood Rd. EA Building, Floor 3, Room 412 Dallas, Texas 75235-73…

Skip to main content Research_Immunotherapy Immunotherapy: Boosting the Immune System to Fight Cancer Our cancer immunotherapy focuses on utilizing both the innate and the adaptive immune system branches for better cancer therapy: (1) In our innate immune system approach, we focus on macrophages, whi…

The Smith Lab strives to develop enabling tools for organic synthesis, allowing bioactive molecules of great complexity to be prepared in a concise and sustainable fashion.

Our lab researches Cerebellar Dysfunction, Brainstem Dysfunction, High-Throughput Screen, and Human Studies.

The Cardiovascular Pharmacotherapy Research Lab integrates molecular epidemiology, clinical pharmacology, clinical trials and population health science to identify new pathways and therapeutic strategies for the prevention of heart failure. Our team conducts cross-disciplinary, mechanism-focused clinical research to translate biologic discoveries into interventions with meaningful public health impact.

The Douglas lab seeks to understand how stress response pathways alter cell physiology, and ultimately influence the aging process and human disease.